Jing Du

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Long Non Coding Rna

Top Venues

Cell death discovery

Technology in cancer research & treatment

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Wang, Shuo Zhang, Fengjiao Sun, Weiwei Chen, Cuilan Liu, Hongliang Dong, Bingjie Cui, Lingyu Li, Chunlong Sun, Wen Du, Bin Liu, Wanfeng Fan, Jiong Deng, Clemens A Schmitt, Xiuwen Wang, Jing Du
Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model. Cancer gene therapy (2024)
Shuo Zhang, Yunxiu Xia, Weiwei Chen, Hongliang Dong, Bingjie Cui, Cuilan Liu, Zhiqiang Liu, Fei Wang, Jing Du
Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis. Technology in cancer research & treatment 23 (2024)
Fei Wang, Shuo Zhang, Fengjiao Sun, Weiwei Chen, Cuilan Liu, Hongliang Dong, Bingjie Cui, Lingyu Li, Chunlong Sun, Wen Du, Bin Liu, Wanfeng Fan, Jiong Deng, Clemens A Schmitt, Xiuwen Wang, Jing Du
Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model. Cancer gene therapy 31 (8) (2024)
Shuo Zhang, Yunxiu Xia, Weiwei Chen, Hongliang Dong, Bingjie Cui, Cuilan Liu, Zhiqiang Liu, Fei Wang, Jing Du
Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis. Technology in cancer research & treatment 23 (2024)
Shuo Zhang, Yunxiu Xia, Weiwei Chen, Hongliang Dong, Bingjie Cui, Cuilan Liu, Zhiqiang Liu, Fei Wang, Jing Du
Regulation and Therapeutic Application of Long non-Coding RNA in Tumor Angiogenesis. Technology in cancer research & treatment 23 (2024)
Hongliang Dong, Lili Zeng, Weiwei Chen, Qian Zhang, Fei Wang, Yan Wu, Bingjie Cui, Jingjing Qi, Xin Zhang, Cuilan Liu, Jiong Deng, Yong Yu, Clemens A Schmitt, Jing Du
N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell death discovery 9 (1) (2023)
Hongliang Dong, Lili Zeng, Weiwei Chen, Qian Zhang, Fei Wang, Yan Wu, Bingjie Cui, Jingjing Qi, Xin Zhang, Cuilan Liu, Jiong Deng, Yong Yu, Clemens A Schmitt, Jing Du
N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell death discovery 9 (1) (2023)
Weiwei Chen, Fei Wang, Xinyuan Yu, Jingjing Qi, Hongliang Dong, Bingjie Cui, Qian Zhang, Yan Wu, Jiajia An, Na Ni, Cuilan Liu, Yuchen Han, Shuo Zhang, Clemens A Schmitt, Jiong Deng, Yong Yu, Jing Du
LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression. Oncogene (2023)
Hongliang Dong, Lili Zeng, Weiwei Chen, Qian Zhang, Fei Wang, Yan Wu, Bingjie Cui, Jingjing Qi, Xin Zhang, Cuilan Liu, Jiong Deng, Yong Yu, Clemens A Schmitt, Jing Du
N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell death discovery 9 (1) (2023)
Weiwei Chen, Jiajia An, Jiwei Guo, Yan Wu, Lijuan Yang, Juanjuan Dai, Kaikai Gong, Shuang Miao, Sichuan Xi, Jing Du
Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness. Cancer chemotherapy and pharmacology 81 (5) (2018)